Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
468.00
+8.71 (1.90%)
Aug 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Oncology | 651.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology Growth | 12.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Metabolic | 457.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Metabolic Growth | 31.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Sources of | 431.38M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Sources of Growth | -2.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiology | 230.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cardiology Growth | 8.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Central Nervous System | 181.98M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Central Nervous System Growth | 18.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AVAI | 156.46M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
AVAI Growth | -24.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net New Business Awards | 2.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Net New Business Awards Growth | 12.61% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Backlog | 2.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Total Backlog Growth | -1.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|